How anti-c in a D– patient prompted lifesaving work between a transfusion service and a blood center reference laboratory

References

Nance S, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.
Search in Google Scholar Back to article
Meny GM, Flickinger C, Marcucci CJ. The American Rare Donor Program. Crit Care 2013;28:110.e9–18. doi:10.1016/j.jcrc.2012.02.017.
Search in Google Scholar Back to article
Keller MA, Nance ST, Kavitsky V et al. The American Rare Donor Program: twenty-five years supporting rare blood needs. Immunohematology In press.
Search in Google Scholar Back to article
Maurer J, Nance S, Kavitsky V, Facey D, Keller M. High prevalence antigen negative unit requests: what if it includes being O negative? Transfusion 2021;35(Suppl 3):159–60A.
Search in Google Scholar Back to article
Maurer J, Nance S, Kavitsky V, Facey D, Keller M . When rare blood goes overseas. Transfusion 2021;35(Suppl 3):80A.
Search in Google Scholar Back to article
Makroo R, Gupta R, Bhatia A, et al. Rh phenotype, allele and haplotype frequencies among 51,857 blood donors in North India. Blood Tranfus 2014;12:36–9.
Search in Google Scholar Back to article